Item 5. Other Information
ITEM 5. OTHER INFORMATION
Securities Trading Plans of Directors and Executive Officers
During the three months ended September 30, 2025, none of our directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).
76
Table of Contents
ITEM 6. EXHIBITS
Exhibit
Number Exhibit Description Filed
Herewith Incorporated by
Reference herein
from Form or Schedule Filing Date SEC File/
Reg.
Number
2.1*
Amended and Restated Agreement and Plan of Merger, dated April 28, 2025, by and among the Registrant, Wellfleet Merger Sub, Inc., and Akoya Biosciences, Inc.
8-K 04/29/2025 001-38319
3.1 Amended and Restated Certificate of Incorporation.
8-K 10/02/2025 001-38319
3.2 Restated Bylaws.
8-K
10/02/2025 001-38319
10.1+
Akoya Biosciences , Inc. 2021 Equity Incentive Plan and form of stock option agreement thereunder
S-1/A
04/12/2021 333-254760
10.2+
A koya Biosciences, Inc. Form of Indemnification Agreement
8-K
12/13/2024 001-40344
10.3*
Exclusivity (Equity) Agreement , dated November 17, 2015, by and between Akoya Biosciences, Inc. and The Board of Trustees of the Leland Stanford Junior University
S-1
03/26/2021 333-254760
10.4*
A mendment No. 1 to the License Agreement, dated November 18, 2016, by and between Akoya Biosciences, Inc. and the Boar d of Trustees of the Leland Stanford junior University
S-1
03/26/2021 333-254760
10.5*
L icense and Roy alty Agreement, dated September 28, 2028, by and among Akoya Biosciences, Inc., Perkin Elmer Health Services, Inc., Cambridge Research and Instrumentation, Inc., and VisEn Medical Inc.
S-1
03/26/2021 333-254760
10.6*
E xclusive Patent License A g reement, dated June 26, 2018, by and between Akoya Biosciences, Inc. and the University of Washington
S-1
03/26/2021 333-254760
10.7 Cooperation Agreement, by and between Quanterix Corporation, Kent Lake PR LLC and Kent Lake Partners LP, dated August 4, 2025
8-K
8/4/2025 001-38319
31.1 Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
31.2 Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
32.1 Certifications of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. X
101.SCH XBRL Taxonomy Extension Schema Document. X
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document. X
101.DEF XBRL Taxonomy Extension Definition. X
77
Table of Contents
101.LAB XBRL Taxonomy Extension Label Linkbase Document. X
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document. X
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). X
* Certain exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrant hereby undertakes to furnish supplemental copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the Registrant may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any exhibits or schedules so furnished.
+ Management contract or compensatory plan or arrangement.
78
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUANTERIX CORPORATION
Dated: November 10, 2025
By: /s/ Masoud Toloue, Ph.D.
Masoud Toloue, Ph.D.
President and Chief Executive Officer
(principal executive officer)
Dated: November 10, 2025
By: /s/ Vandana Sriram
Vandana Sriram
Chief Financial Officer
(principal financial officer and principal accounting officer)
79
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.